Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,593 shares at $232.54 ($831K) on 2024-06-25, disclosed to the SEC on 2024-06-26.
Open-market sale of $831k ALNY by CMO & EVP Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $221.71 | 78 | $17K | 2.1% |
| 2 | $224.17 | 17 | $4K | 0.5% |
| 3 | $225.55 | 24 | $5K | 0.7% |
| 4 | $226.82 | 45 | $10K | 1.2% |
| 5 | $228.30 | 169 | $39K | 4.6% |
| 6 | $229.06 | 348 |
| $80K |
| 9.6% |
| 7 | $229.06 | 348 | $80K | 9.6% |
| 8 | $229.93 | 398 | $92K | 11.0% |
| 9 | $229.93 | 398 | $92K | 11.0% |
| 10 | $231.59 | 129 | $30K | 3.6% |
| 11 | $232.54 | 283 | $66K | 7.9% |
| 12 | $232.54 | 283 | $66K | 7.9% |
| 13 | $233.53 | 151 | $35K | 4.2% |
| 14 | $234.66 | 242 | $57K | 6.8% |
| 15 | $234.66 | 242 | $57K | 6.8% |
| 16 | $235.19 | 219 | $52K | 6.2% |
| 17 | $235.19 | 219 | $52K | 6.2% |
| Total | $231.31 avg | 3,593 | $831K | 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |